High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients

Kwonjune J Seung¹, Molly F Franke², Catherine Hewison³, Helena Huerga⁴, Uzma Khan⁵, Carole D Mitnick⁶; end TB Study Group

Affiliations

¹ Partners In Health, Boston, USA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA; Division of Global Health Equity, Brigham and Women's Hospital, Boston, USA. Electronic address: kjseung@pih.org.
² Partners In Health, Boston, USA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA.
³ Medical Department, Médecins Sans Frontières, Paris, France.
⁴ Field Epidemiology Department, Epicentre, Paris, France.
⁵ Interactive Research and Development, Dubai, United Arab Emirates.
⁶ Partners In Health, Boston, USA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA; Division of Global Health Equity, Brigham and Women's Hospital, Boston, USA.

PMID: 32147086
DOI: 10.1016/j.jhep.2019.10.018

Comment

High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients

Kwonjune J Seung et al. J Hepatol. 2020 May.

. 2020 May;72(5):1028-1029.

doi: 10.1016/j.jhep.2019.10.018. Epub 2020 Mar 6.

Authors

Kwonjune J Seung¹, Molly F Franke², Catherine Hewison³, Helena Huerga⁴, Uzma Khan⁵, Carole D Mitnick⁶; end TB Study Group

Affiliations

¹ Partners In Health, Boston, USA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA; Division of Global Health Equity, Brigham and Women's Hospital, Boston, USA. Electronic address: kjseung@pih.org.
² Partners In Health, Boston, USA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA.
³ Medical Department, Médecins Sans Frontières, Paris, France.
⁴ Field Epidemiology Department, Epicentre, Paris, France.
⁵ Interactive Research and Development, Dubai, United Arab Emirates.
⁶ Partners In Health, Boston, USA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA; Division of Global Health Equity, Brigham and Women's Hospital, Boston, USA.

PMID: 32147086
DOI: 10.1016/j.jhep.2019.10.018

Erratum in

Corrigendum to 'High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients' [J Hepatol 72 (2020) 1028-1029].
Seung KJ, Franke MF, Hewison C, Huerga H, Khan U, Mitnick CD; endTB Study Group. Seung KJ, et al. J Hepatol. 2022 Aug;77(2):583. doi: 10.1016/j.jhep.2022.04.012. Epub 2022 May 14. J Hepatol. 2022. PMID: 35581037 No abstract available.

No abstract available

Keywords: Hepatitis C; Multidrug-resistant tuberculosis; Tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The endTB Consortium coordinated donations of delamanid (Otsuka Pharmaceutical) and bedaquiline (Janssen) to be used for treatment by some of the patients included in the endTB Observational Study. All authors report no additional potential conflicts of interest. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment in

Reply to: 'High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients'.
Solomon SS, McFall AM, Lucas GM, Mehta SH. Solomon SS, et al. J Hepatol. 2020 May;72(5):1029-1030. doi: 10.1016/j.jhep.2020.01.020. Epub 2020 Feb 10. J Hepatol. 2020. PMID: 32057917 No abstract available.

Comment on

Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.
Solomon SS, Quinn TC, Solomon S, McFall AM, Srikrishnan AK, Verma V, Kumar MS, Laeyendecker O, Celentano DD, Iqbal SH, Anand S, Vasudevan CK, Saravanan S, Thomas DL, Sachdeva KS, Lucas GM, Mehta SH. Solomon SS, et al. J Hepatol. 2020 Jan;72(1):67-74. doi: 10.1016/j.jhep.2019.09.022. Epub 2019 Oct 8. J Hepatol. 2020. PMID: 31604081 Free PMC article. Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- ClinicalTrials.gov

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients

Affiliations

High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients

Authors

Affiliations

Erratum in

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical